The investment fund Stratus SCP Brasil Coinvestimento II (Stratus) acquired 100% of Investfarma S.A., a company that controls the pharmacy chain Poupafarma, as well as other related companies.
Stratus would have bought all the companies that make up Investfarma, in a series of operations approved by the Administrative Council of Economic Defense (CADE).
In October 2018, CADE approved the acquisition of Farma Participacoes, arguing that competition would not be affected by these incursions, considering Stratus’ participation in other sectors such as gyms, collection companies and private transportation.
Full Content: LexLatin
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Pushes Review of CoStar’s Commercial Real Estate Antitrust Case
Jan 31, 2024 by
CPI
UK’s CMA Investigates Ardonagh’s Atlanta Group and Markerstudy Merger
Jan 31, 2024 by
CPI
Greenberg Traurig Grow Financial Regulatory and Compliance Practice
Jan 31, 2024 by
CPI
Dutch Regulator Fines Uber €10 Million for Privacy Violations
Jan 31, 2024 by
CPI
DOJ Investigates AI Competition, Eyes Microsoft’s OpenAI Deal: Bloomberg
Jan 31, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – The Rule(s) of Reason
Jan 29, 2024 by
CPI
Evolving the Rule of Reason for Legacy Business Conduct
Jan 29, 2024 by
CPI
The Object Identity
Jan 29, 2024 by
CPI
In Praise of Rules-Based Antitrust
Jan 29, 2024 by
CPI
The Future of State AG Antitrust Enforcement and Federal-State Cooperation
Jan 29, 2024 by
CPI